NASDAQ:NUVL News 14 January 2026

Nuvalent stock jumps as FDA review clock sharpens focus on 2026 launch plans

Nuvalent shares rose about 6% Wednesday after the company set 2026 targets for its lung cancer drug and reported $1.4 billion in cash at year-end. The FDA accepted its new drug application for zidesamtinib, with a decision expected by Sept. 18, 2026. Nuvalent plans a U.S. launch if approved and aims to file for a second lung cancer drug in early 2026.

14 January 2026

NASDAQ:NUVL·Pharmaceuticals·Stock Market

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.02.2026

8 February 2026

LIVEMarkets rolling coverageStarted: February 8, 2026, 12:00 AM ESTUpdated: February 8, 2026, 12:19 AM EST Sprinklr (CXM) Undervalued Amid Share Price Drop, AI Growth Potential Assessed February 8, 2026, 12:11 AM EST. Sprinklr (CXM) shares hover near $6, reflecting a 21% drop over 30 days and nearly 31% decline year-to-date. Despite negative returns stretching back three years, some analysts see an intrinsic value of around $11, suggesting the stock may be undervalued. The AI-driven customer experience platform is integrating advanced AI functionalities across marketing and customer service products to capitalize on rising demand for AI-powered analytics. Key risks include potential

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026

Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026

Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026

MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.